vs

Side-by-side financial comparison of BIT ORIGIN Ltd (BTOG) and INVO Fertility, Inc. (IVF). Click either name above to swap in a different company.

BIT ORIGIN Ltd is the larger business by last-quarter revenue ($2.9M vs $1.8M, roughly 1.6× INVO Fertility, Inc.). INVO Fertility, Inc. runs the higher net margin — -150.5% vs -244.4%, a 93.8% gap on every dollar of revenue.

Origin Systems, Inc. was an American video game developer based in Austin, Texas. It was founded on March 3, 1983, by Richard Garriott and his brother Robert. Origin is best known for their groundbreaking work in multiple genres of video games, such as the Ultima and Wing Commander series. The company was purchased by Electronic Arts in 1992.

INVO Fertility, Inc. is a specialized healthcare company focused on delivering accessible assisted reproductive technology solutions. It develops, manufactures and markets the patented INVOcell intravaginal culture system for in vitro fertilization procedures, serving fertility clinics and patients across North America, Europe and other global regions, with a mission to reduce barriers to high-quality fertility care.

BTOG vs IVF — Head-to-Head

Bigger by revenue
BTOG
BTOG
1.6× larger
BTOG
$2.9M
$1.8M
IVF
Higher net margin
IVF
IVF
93.8% more per $
IVF
-150.5%
-244.4%
BTOG

Income Statement — Q2 FY2024 vs Q3 FY2025

Metric
BTOG
BTOG
IVF
IVF
Revenue
$2.9M
$1.8M
Net Profit
$-7.1M
$-2.6M
Gross Margin
Operating Margin
-233.8%
-93.1%
Net Margin
-244.4%
-150.5%
Revenue YoY
22.6%
Net Profit YoY
-62.2%
EPS (diluted)
$-1.99
$-0.77

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BTOG
BTOG
IVF
IVF
Q3 25
$1.8M
Q2 25
$1.9M
Q1 25
$1.6M
Q4 24
$1.7M
Q3 24
$1.4M
Q2 24
$1.8M
Q1 24
$1.6M
Q4 23
$2.9M
$1.4M
Net Profit
BTOG
BTOG
IVF
IVF
Q3 25
$-2.6M
Q2 25
$-5.3M
Q1 25
$-17.4M
Q4 24
$-3.6M
Q3 24
$-1.6M
Q2 24
$-2.2M
Q1 24
$-1.6M
Q4 23
$-7.1M
$-2.0M
Gross Margin
BTOG
BTOG
IVF
IVF
Q3 25
Q2 25
Q1 25
35.2%
Q4 24
41.4%
Q3 24
31.0%
Q2 24
53.1%
Q1 24
45.3%
Q4 23
33.0%
Operating Margin
BTOG
BTOG
IVF
IVF
Q3 25
-93.1%
Q2 25
-160.4%
Q1 25
-1042.1%
Q4 24
-202.0%
Q3 24
-90.7%
Q2 24
-100.9%
Q1 24
-95.7%
Q4 23
-233.8%
-109.2%
Net Margin
BTOG
BTOG
IVF
IVF
Q3 25
-150.5%
Q2 25
-283.6%
Q1 25
-1060.1%
Q4 24
-211.3%
Q3 24
-113.8%
Q2 24
-122.2%
Q1 24
-101.3%
Q4 23
-244.4%
-144.4%
EPS (diluted)
BTOG
BTOG
IVF
IVF
Q3 25
$-0.77
Q2 25
$-13.30
Q1 25
$-12.53
Q4 24
$14.86
Q3 24
$-15.11
Q2 24
$-22.39
Q1 24
$-7.55
Q4 23
$-1.99
$-59.51

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BTOG
BTOG
IVF
IVF
Cash + ST InvestmentsLiquidity on hand
$6.9M
Total DebtLower is stronger
$2.0M
Stockholders' EquityBook value
$9.0M
$5.8M
Total Assets
$13.5M
$18.8M
Debt / EquityLower = less leverage
0.34×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BTOG
BTOG
IVF
IVF
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
Q4 23
$6.9M
Total Debt
BTOG
BTOG
IVF
IVF
Q3 25
$2.0M
Q2 25
$4.8M
Q1 25
Q4 24
$7.5M
Q3 24
Q2 24
Q1 24
Q4 23
Stockholders' Equity
BTOG
BTOG
IVF
IVF
Q3 25
$5.8M
Q2 25
$2.6M
Q1 25
$3.3M
Q4 24
$12.7M
Q3 24
$-23.3K
Q2 24
$1.4M
Q1 24
$10.2K
Q4 23
$9.0M
$892.8K
Total Assets
BTOG
BTOG
IVF
IVF
Q3 25
$18.8M
Q2 25
$19.3M
Q1 25
$31.7M
Q4 24
$46.4M
Q3 24
$17.0M
Q2 24
$17.8M
Q1 24
$17.3M
Q4 23
$13.5M
$18.5M
Debt / Equity
BTOG
BTOG
IVF
IVF
Q3 25
0.34×
Q2 25
1.83×
Q1 25
Q4 24
0.59×
Q3 24
Q2 24
Q1 24
Q4 23

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BTOG
BTOG
IVF
IVF
Operating Cash FlowLast quarter
$-4.6M
$-1.8M
Free Cash FlowOCF − Capex
$-1.8M
FCF MarginFCF / Revenue
-101.6%
Capex IntensityCapex / Revenue
0.5%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-7.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BTOG
BTOG
IVF
IVF
Q3 25
$-1.8M
Q2 25
$-1.7M
Q1 25
$-3.5M
Q4 24
$-617.4K
Q3 24
$-640.8K
Q2 24
$-1.5M
Q1 24
$-260.6K
Q4 23
$-4.6M
$-714.9K
Free Cash Flow
BTOG
BTOG
IVF
IVF
Q3 25
$-1.8M
Q2 25
$-1.7M
Q1 25
$-3.6M
Q4 24
$-696.3K
Q3 24
Q2 24
$-1.5M
Q1 24
$-310.3K
Q4 23
FCF Margin
BTOG
BTOG
IVF
IVF
Q3 25
-101.6%
Q2 25
-92.6%
Q1 25
-216.9%
Q4 24
-40.6%
Q3 24
Q2 24
-82.3%
Q1 24
-19.7%
Q4 23
Capex Intensity
BTOG
BTOG
IVF
IVF
Q3 25
0.5%
Q2 25
0.5%
Q1 25
0.9%
Q4 24
4.6%
Q3 24
0.0%
Q2 24
3.0%
Q1 24
3.2%
Q4 23

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons